Evolus, Inc.
USD7.13
+0.00 (+0.00%)
CEO
David Moatazedi
IPO Date
2018-02-08
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$7.10
Prev. Close
$7.13
Day Low
$6.95
Day High
$7.18
52W Low
$3.86
52W High
$10.20
Market Cap
$0.47B
Volume
0.67M
| -13.6 |
| 31 Dec 2023 | FY | 69.5% | -30.5% | 298.2% | -32.6% | -6.12 | 2.33 | -9.7 |
| 31 Dec 2022 | FY | 60.4% | -50.1% | -402.2% | -41.8% | 4.02 | 2.17 | -5.7 |
| 31 Dec 2021 | FY | 56.3% | -47.0% | -57.2% | -18.2% | 0.91 | 3.10 | -6.9 |
| 31 Dec 2020 | FY | 67.6% | -288.3% | 223.4% | -78.0% | -1.90 | 0.71 | -0.7 |
| 31 Dec 2019 | FY | 77.1% | -257.8% | -113.3% | -37.4% | 1.22 | 6.23 | -3.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 38.1% | -27.3% | -0.14 | 17.88 | -6.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 5.9% | -2.9% | -2.80 | 0.34 | -60.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 282.4% | -25.9% | -8.41 | 0.00 | -10.7 |
| 824.5 |
| 30 Sept 2025 | Q3 | 66.5% | -22.8% | 54.7% | -7.2% | -5.39 | 2.02 | -6.3 |
| 30 Jun 2025 | Q2 | 65.3% | -24.7% | 91.9% | -7.5% | -8.31 | 2.27 | -8.7 |
| 31 Mar 2025 | Q1 | 68.1% | -27.6% | 286.1% | -8.9% | -19.72 | 2.34 | -10.1 |
| 31 Dec 2024 | Q4 | 63.8% | -8.6% | -123.0% | -2.9% | 23.54 | 2.40 | -25.1 |
| 30 Sept 2024 | Q3 | 70.2% | -31.4% | -325.5% | -8.3% | 1.47 | 2.47 | -13.3 |
| 30 Jun 2024 | Q2 | 70.3% | -17.0% | -58.8% | -4.9% | 6.56 | 2.92 | -15.3 |
| 31 Mar 2024 | Q1 | 68.3% | -22.1% | -71.1% | -5.8% | 6.87 | 3.21 | -15.4 |
| 31 Dec 2023 | Q4 | 63.6% | -19.4% | 57.2% | -6.3% | -6.12 | 2.33 | -12.7 |